1 day ago · In addition, Metsera has granted the underwriters a 30-day option to purchase up to an additional 2,291,666 shares of common stock at the initial public offering price less underwriting discounts ...

1 day ago · In addition, Metsera has granted the underwriters a 30-day option to purchase up to an additional 2,291,666 shares of common stock at the initial public offering price less underwriting discounts ...

1 day ago · Metsera, Inc., a clinical-stage biotechnology company specializing in obesity treatments through injectable and oral hormone analog peptides, announced the pricing of its initial public offering ...

1 day ago · Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech ...

2 days ago · Metsera and Maze Therapeutics priced initial public offerings on Jan. 30, 2025, listing their shares on the Nasdaq stock exchange. ... in a pair of new stock offerings priced Thursday. Metsera, an obesity drug developer, sold nearly 15.3 million shares at $18 apiece in an offering that ranks as one of the industry’s largest since 2022, ...

10 hours ago · After initially offering its common stock to the public at $18.00 per share, the company's shares opened for trading at a higher price of $25.50. The initial public offering (IPO) consisted of 15,277,778 shares of the company's common stock. The shares are now trading under the ticker symbol "MTSR" on the Nasdaq Global Select Market.

1 day ago · Metsera (Nasdaq: MTSR), a clinical-stage biotech company focused on developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for obesity treatment, has announced the pricing of its initial public offering.The company is offering 15,277,778 shares of common stock at $18.00 per share, expecting to raise gross proceeds of approximately $275.0 million ...

10 hours ago · After initially offering its common stock to the public at $18.00 per share, the company's shares opened for trading at a higher price of $25.50. The initial public offering (IPO) consisted of ...

4 days ago · (Bloomberg) -- Metsera Inc. is seeking to raise $292 million in an initial public offering, joining a clutch of health-care firms set to make their debuts as public companies. The New York-based firm plans to market 17.2 million shares for $15 to $17 per share, according to its filing on Monday with the US Securities and Exchange Commission.

10 hours ago · After initially offering its common stock to the public at $18.00 per share, the company's shares opened for trading at a higher price of $25.50. The initial public offering (IPO) consisted of 15,277,778 shares of the company's common stock. ... In addition to the initial offering, Metsera has also provided the underwriters with a 30-day option ...